142 related articles for article (PubMed ID: 2262880)
1. [Augmentation of pirarubicin cytotoxicity by chlorpromazine in doxorubicin-resistant mouse P388 leukemia cells].
Shibata H; Sano F; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
Yakugaku Zasshi; 1990 Sep; 110(9):678-81. PubMed ID: 2262880
[TBL] [Abstract][Full Text] [Related]
2. [Modulation of anthracycline resistance by reserpine in P388 leukemia cells].
Shibata H; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):1-6. PubMed ID: 1889760
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium chloride on pirarubicin induced cell killing in P388 mouse leukemia cells.
Furusawa S; Fujimura T; Hayasaka S; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):75-86. PubMed ID: 1882129
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of pirarubicin activity in multidrug resistant cells by rifampicin.
Furusawa S; Nakano S; Wu J; Sasaki K; Takayanagi M; Takayanagi Y
Biol Pharm Bull; 1997 Dec; 20(12):1303-6. PubMed ID: 9448109
[TBL] [Abstract][Full Text] [Related]
7. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines.
Liu QY; Tan BK
Life Sci; 2000; 67(10):1207-18. PubMed ID: 10954054
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis induced by doxorubicin and cinchonine in P388 multidrug-resistant cells.
Furusawa S; Nakano S; Wu J; Sakaguchi S; Takayanagi M; Sasaki KI; Satoh S
J Pharm Pharmacol; 2001 Jul; 53(7):1029-39. PubMed ID: 11480538
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
[TBL] [Abstract][Full Text] [Related]
10. Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Turinic R; Valenzuela R
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):799-806. PubMed ID: 6540180
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic influences on doxorubicin-sensitive or -resistant P388 leukemia cells.
D'Amico C; Crescimanno M; Armata MG; Leonardi V; Palazzoadriano M; D'Alessandro N
Anticancer Res; 1992; 12(6B):2253-6. PubMed ID: 1338280
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of 1-methyl-3-propyl-7-butylxanthine on the antitumor activity of doxorubicin against doxorubicin-resistant P388 leukemia.
Sadzuka Y; Sugiyama T; Sawanishi H; Miyamoto K
Cancer Lett; 1999 Apr; 138(1-2):5-11. PubMed ID: 10378767
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
Krishan A; Sauerteig A; Gordon K; Swinkin C
Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163
[TBL] [Abstract][Full Text] [Related]
14. Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells.
Sadzuka Y; Egawa Y; Sawanishi H; Miyamoto K; Sonobe T
Toxicol Lett; 2002 Sep; 135(1-2):137-44. PubMed ID: 12243872
[TBL] [Abstract][Full Text] [Related]
15. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M
Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
18. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.
Streeter DG; Johl JS; Gordon GR; Peters JH
Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646
[TBL] [Abstract][Full Text] [Related]
19. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
